A narrative review estimates up to 15% of male infertility stems from immune dysregulation at the blood-testis barrier
Journal: Fertility and Sterility | Published: 2026-03-17 | Type: Narrative Review | PMID: 41856349 Authors: Babcock RL, Haynes A, Dufour JM (Texas Tech University Health Sciences Center — cell biology, biochemistry, and urology) Funding/COI: Funding not listed; all authors declare no conflicts of interest
The testes operate under an unusual immunological truce: Sertoli cells form a physical and chemical barrier that prevents the immune system from recognizing developing sperm as foreign and destroying them. This review covers how that truce breaks down — through infection, cancer, or trauma — and what happens to fertility when it does. It's a mechanisms paper with clinical framing, not a study generating new data.
This is a views-and-reviews article — a narrative synthesis, not a systematic review. There is no original data, no meta-analysis, and no pre-registered search protocol. The authors drew on existing literature to explain the mechanisms of testicular immune privilege and its clinical relevance, which limits how much any specific claim can be independently verified from this paper alone.
The "up to 15%" estimate for immune-related male infertility is a ceiling figure, not a measured point prevalence. Without access to the full text it's impossible to evaluate its sourcing. Narrative reviews are inherently susceptible to citation selection bias.
A solid conceptual map for anyone who needs to understand the biology of testicular immune privilege and why it matters clinically, but not a paper to cite as primary evidence for any specific prevalence claim. The 15% figure is what most people will pull from this — and it deserves scrutiny, since it's a ceiling estimate with unknown sourcing rather than a measured finding. Read it to orient yourself to the mechanism, not to anchor a statistic.